Joan Genescà

15.8k total citations · 3 hit papers
149 papers, 6.9k citations indexed

About

Joan Genescà is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Joan Genescà has authored 149 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Hepatology, 110 papers in Epidemiology and 45 papers in Surgery. Recurrent topics in Joan Genescà's work include Liver Disease Diagnosis and Treatment (100 papers), Liver Disease and Transplantation (89 papers) and Hepatitis C virus research (27 papers). Joan Genescà is often cited by papers focused on Liver Disease Diagnosis and Treatment (100 papers), Liver Disease and Transplantation (89 papers) and Hepatitis C virus research (27 papers). Joan Genescà collaborates with scholars based in Spain, Canada and United States. Joan Genescà's co-authors include Rafael Esteban, Salvador Augustín, J. Guardia, Antonio González, Rafael Simó, Cristina Hernández, Juan Ignacio Esteban, Marı́a Martell, Albert Lecube and Juan G. Abraldeṣ and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Joan Genescà

145 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution

1992 777 citations Marı́a Martell, Juan Ignacio Esteban et al. profile →
HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN

1989 751 citations Rafael Esteban, Antonio González et al. The Lancet profile →
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial

2019 392 citations Càndid Villanueva, Agustı́n Albillos et al. The Lancet profile →

Peers

Countries citing papers authored by Joan Genescà

Since Specialization

Citations

This map shows the geographic impact of Joan Genescà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan Genescà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan Genescà more than expected).

Fields of papers citing papers by Joan Genescà

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan Genescà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan Genescà. The network helps show where Joan Genescà may publish in the future.

Co-authorship network of co-authors of Joan Genescà

This figure shows the co-authorship network connecting the top 25 collaborators of Joan Genescà. A scholar is included among the top collaborators of Joan Genescà based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan Genescà. Joan Genescà is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Refining the Baveno VII criteria for clinically significant portal hypertension: An individual patient data meta-analysis 2025 ·Journal of Hepatology ·(unknown), Mònica Pons, Thomas Reiberger, Mattias Mandorfer, Mathias Jachs, Georg Semmler, Antonio Colecchia, Luigi Colecchia, Elton Dajti, Christophe Bureau, Hélène Larrue, Ivica Grgurević, (unknown), José Ignacio Fortea, Ángela Puente, Annalisa Berzigotti, Emmanuel Tsochatzis, Jaime Bosch, Juan G. Abraldeṣ, Joan Genescà	0
2	Noninvasive Assessment of Portal Hypertension 2024 ·Clinics in Liver Disease ·(unknown), (unknown), Mònica Pons, Joan Genescà	1
3	Relationship between updated MELD and prognosis in alcohol-associated hepatitis: Opportunities for more efficient trial design 2024 ·Hepatology Communications ·(unknown), Meritxell Ventura‐Cots, Yu Jun Wong, Joan Genescà, Francisco Bosques‐Padilla, Robert S. Brown, Philippe Mathurin, Alexandre Louvet, Debbie L. Shawcross, Vı́ctor Vargas, Elizabeth C. Verna, Bernd Schnabl, Joan Caballería, (unknown), Patrick S. Kamath, Michael R. Lucey, Guadalupe García‐Tsao, Ramón Bataller, Juan G. Abraldeṣ	2
4	Zinc supplementation to improve prognosis in patients with compensated advanced chronic liver disease: a multicenter, randomized, double-blind, placebo-controlled clinical trial 2024 ·Hepatology Communications ·(unknown), (unknown), (unknown), Mònica Pons, (unknown), Joan Genescà	0
5	Progressive systemic inflammation precedes decompensation in compensated cirrhosis 2024 ·JHEP Reports ·(unknown), Càndid Villanueva, Joan Genescà, Juan Carlos García‐Pagán, (unknown), José Luís Calleja, Carles Aracil, Rafael Bañares, Luís Téllez, (unknown), Rosa M. Morillas, María Poca, Beatriz Peñas, Salvador Augustín, Juan G. Abraldeṣ, Edilmar Alvarado‐Tápias, Jackie Bosch, Agustı́n Albillos	4
6	Prediction of clinical events by liver stiffness and chronic kidney disease by NAFLD in patients with type-2 diabetes 2023 ·Gastroenterología y Hepatología (English Edition) ·Jesús Rivera‐Esteban, Mònica Pons, (unknown), Ramiro Manzano-Núñez, Cristina Hernández, Olga Simó‐Servat, Jordi Bañeras, María José Soler, Daniel Serón, Anna Boixadera, Salvador Augustín, Rafael Simó, Ignacio Ferreira‐González, Joan Genescà, Juan M. Pericàs	1
7	Review article: The need for more efficient and patient‐oriented drug development pathways in NASH—setting the scene for platform trials 2023 ·Alimentary Pharmacology & Therapeutics ·Juan M. Pericàs, Nicholas A. Di Prospero, Quentin M. Anstee, (unknown), Mette Skalshøi Kjær, Jesús Rivera‐Esteban, Franz Koenig, (unknown), Raluca Pais, Ramiro Manzano-Núñez, Joan Genescà, Frank Tacke, Vlad Ratziu, (unknown)	4
8	Proteomic Analysis of Dysfunctional Liver Sinusoidal Endothelial Cells Reveals Substantial Differences in Most Common Experimental Models of Chronic Liver Diseases 2023 ·International Journal of Molecular Sciences ·(unknown), Mikel Azkargorta, (unknown), (unknown), Imma Raurell, (unknown), Juan M. Pericàs, Diana Hide, Félix Elortza, Joan Genescà, Marı́a Martell	3
9	Quantifying the benefit of nonselective beta-blockers in the prevention of hepatic decompensation: A Bayesian reanalysis of the PREDESCI trial 2023 ·Hepatology ·Ian Rowe, Càndid Villanueva, (unknown), Ferràn Torres, Agustı́n Albillos, Joan Genescà, Juan Carlos García‐Pagán, Dhiraj Tripathi, Peter Hayes, Jaime Bosch, Juan G. Abraldeṣ, (unknown)	7
10	Point-of-Care Noninvasive Prediction of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease 2023 ·Clinical Gastroenterology and Hepatology ·Mònica Pons, Jesús Rivera‐Esteban, Mang Ma, (unknown), Adèle Delamarre, (unknown), (unknown), Grace Lai–Hung Wong, Terry Cheuk‐Fung Yip, Grazia Pennisi, (unknown), Calogero Cammà, Salvatore Petta, Victor de Lédinghen, Vincent Wai‐Sun Wong, Salvador Augustín, Juan M. Pericàs, Juan G. Abraldeṣ, Joan Genescà	27
11	Prediction of clinical events by liver stiffness and chronic kidney disease by NAFLD in patients with type-2 diabetes 2022 ·Gastroenterología y Hepatología ·Jesús Rivera‐Esteban, Mònica Pons, (unknown), Ramiro Manzano-Núñez, Cristina Hernández, Olga Simó‐Servat, Jordi Bañeras, María José Soler, Daniel Serón, Anna Boixadera, Salvador Augustín, Rafael Simó, Ignacio Ferreira‐González, Joan Genescà, Juan M. Pericàs	4
12	Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis 2021 ·Journal of Hepatology ·Càndid Villanueva, Agustı́n Albillos, Joan Genescà, Juan Carlos García‐Pagán, Anna Brujats, José Luís Calleja, Carles Aracil, Rafael Bañares, Rosa M. Morillas, María Poca, Beatriz Peñas, Salvador Augustín, Juan G. Abraldeṣ, Edilmar Alvarado, Ferràn Torres, Jaime Bosch	39
13	<p>Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory</p> 2020 ·International Journal of COPD ·(unknown), Alexa Núñez, Míriam Barrecheguren, Cristina Esquinas, Mònica Pons, (unknown), (unknown), Albert Blanco‐Grau, Roser Ferrer, Joan Genescà, Marc Miravitlles, Francisco Rodríguez‐Frias	4
14	β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial breakdown → 2019 ·The Lancet ·Càndid Villanueva, Agustı́n Albillos, Joan Genescà, Juan Carlos García‐Pagán, José Luís Calleja, Carles Aracil, Rafael Bañares, Rosa M. Morillas, María Poca, Beatriz Peñas, Salvador Augustín, Juan G. Abraldeṣ, Edilmar Alvarado, Ferràn Torres, Jaime Bosch	392
15	Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis 2017 ·Hepatology ·Teresa García‐Lezana, Imma Raurell, Miren Bravo, (unknown), María Teresa Salcedo, Alba Santiago, (unknown), Chaysavanh Manichanh, Joan Genescà, Marı́a Martell, Salvador Augustín	101
16	Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver 2017 ·Gastroenterología y Hepatología (English Edition) ·Marta Martín–Llahí, Agustı́n Albillos, Rafael Bañares, Annalisa Berzigotti, Ángeles García‐Criado, Joan Genescà, Virginia Hernández–Gea, (unknown), (unknown), José Mateo, C.A. Navascués, Ángela Puente, Marta Romero-Gutiérrez, Macarena Simón‐Talero, Luís Téllez, Fanny Turón, Cándido Villanueva, Roberto Zarrabeitia, Juan Carlos García‐Pagán	15
17	Basal values and changes of liver stiffness predict the risk of disease progression in compensated advanced chronic liver disease 2016 ·Digestive and Liver Disease ·Mònica Pons, Macarena Simón‐Talero, Laura Millán, Meritxell Ventura‐Cots, (unknown), Salvador Augustín, Joan Genescà	12
18	Cardiac alterations in cirrhosis: reversibility after liver transplantation 2004 ·Journal of Hepatology ·Mireia Torregrosa, (unknown), Laura Dos, Rosa Segura, Antonio González, Artur Evangelista, Joan Martí i Castell, Carlos Margarit, Rafael Esteban, Jaume Guàrdia, Joan Genescà	230
19	Hepatitis C virus markers in patients with acute post-transfusion hepatitis treated with interferon alfa-2b. 1993 ·Gut ·Joan Genescà, Juan Ignacio Esteban, Josep Quer, L Viladomiu, (unknown), Rafael Esteban, J Guàrdia	15
20	Clinical Correlation and Genetic Polymorphism of the Human Immunodeficiency Virus Proviral DNA Obtained after Polymerase Chain Reaction Amplification 1990 ·The Journal of Infectious Diseases ·Joan Genescà, Ruixue Wang, H. J. Alter, J W Shih	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact